Interview with: Robert Klimasewski, CEO - featuring: their medical image analysis services and proprietary software algorithms that can assemble hundreds of separate medical images taken during an MRI session into a single, three-dimensional model, bringing a new and previously unobtainable source of data to clinical researchers. |
|
| VirtualScopics, Inc. (VSCP-OTC: BB) | |
|
|
CURRENT ISSUE | COVER ARCHIVES | INDEX | CONTACT | FINANCIALS | MARKETING SERVICES | HOME PAGE |
|
This is a printer friendly page! VirtualScopics offers the
pharmaceutical and medical device companies an advanced medical image analysis service
that can save them hundreds of millions of dollars as they bring their drugs or therapy
from the research phase to the pharmacist shelf
|
|
“I think the
biggest challenge is to get the message out to the pharmaceutical and medical device
companies, that we have a powerful image-based biomarker analysis service that can save
them hundreds of millions of dollars; it costs a billion dollars to get a drug from
research phase to the pharmacist shelf. Many times these companies go way down the road
until they find out the drug is ineffective. We can tell them that their drug is going to
be effective much earlier and we can allow them to save time by improving the accuracy by
which we can assess the effectiveness of the drug. That is the message we have to get out.
I think as we go to trade shows, participate in conferences, get papers published in peer
reviewed journals, and as people begin to see results that will be published from our work
in various therapeutic areas, then they are going to understand the value
proposition.” |
|
